<?xml version="1.0" encoding="ISO-8859-1"?>
<rss version="2.0">
<channel>
<title>Decadron (Dexamethasone)</title>
<link>http://genericdecadron.infohttp://genericdecadron.info/</link>
<description>Decadron (Dexamethasone)</description>
<item>
<title>Decadron News - Decadron and all</title>
<link>http://genericdecadron.infohttp://genericdecadron.info/Decadron/Decadron-and-all/</link>
<description><![CDATA[<p><br /><img alt="" height="1" width="1" /><a rel="nofollow" target="_blank" href="http://news.google.com/news/url?fd=R&amp;sa=T&amp;url=http%3A%2F%2Fwww.myelomabeacon.com%2Fnews%2F2010%2F02%2F25%2Fthalidomide-as-induction-and-maintenance-therapy-improves-response-rates-in-multiple-myeloma-patients%2F&amp;usg=AFQjCNFSX1MB6SN7Abk9O4PPAppb7Mm2JA">Thalidomide As Induction And Maintenance Therapy Improves Response Rates In </a><br />The Myeloma Beacon<br /> and dexamethasone (Decadron) [TAD] as induction therapy. All patients received high-dose melphalan (Alkeran) with an autologous stem cell transplant, <br /><br /><a rel="nofollow" target="_blank" class="p" href="http://news.google.com/news/more?pz=1&amp;ned=us&amp;ncl=dNyKsXPFbabQDEM"></a></p><p><br /><img alt="" height="1" width="1" /><a rel="nofollow" target="_blank" href="http://news.google.com/news/url?fd=R&amp;sa=T&amp;url=http%3A%2F%2Fwww.kelowna.com%2F2010%2F02%2F17%2Fchuck-poulsen-pharmaceutical-companies-a-pain-in-the-butt&amp;usg=AFQjCNFaxw_wGesYhYYtkjsGWqyMg2bEsg">Chuck Poulsen: Pharmaceutical companies a pain in the butt</a><br />Kelowna.com<br />The gold standard is an injection of Decadron (dexamethasone). That&#39;s a powerful corticosteroid. An attack of edema was coming on so I went to the local <br /><br /><a rel="nofollow" target="_blank" class="p" href="http://news.google.com/news/more?pz=1&amp;ned=us&amp;ncl=dV4cBEAbF7x-_zM">and more&nbsp;&raquo;</a></p><p><a rel="nofollow" target="_blank" href="http://news.google.com/news/url?fd=R&amp;sa=T&amp;url=http%3A%2F%2Fwww.osnsupersite.com%2Fview.aspx%3Frid%3D61205&amp;usg=AFQjCNEIcznSFHm2Mn5FLS4Ypy8G_5Z0Eg"><img src="http://nt0.ggpht.com/news/tbn/mGCe5_tzYcecsM/6.jpg" alt="" border="1" width="80" height="80" /><br />OSN SuperSite</a><br /><img alt="" height="1" width="1" /><a rel="nofollow" target="_blank" href="http://news.google.com/news/url?fd=R&amp;sa=T&amp;url=http%3A%2F%2Fwww.osnsupersite.com%2Fview.aspx%3Frid%3D61205&amp;usg=AFQjCNEIcznSFHm2Mn5FLS4Ypy8G_5Z0Eg">Surgical technique determines success of ECP</a><br />OSN SuperSite<br />His team injects Decadron (dexamethasone, Merck) into a patient&#39;s eye immediately after surgery and then continues to treat them with it intravenously <br /><br /><a rel="nofollow" target="_blank" class="p" href="http://news.google.com/news/more?pz=1&amp;ned=us&amp;ncl=dXss72pvl1NYqoM"></a></p><p><br /><img alt="" height="1" width="1" /><a rel="nofollow" target="_blank" href="http://news.google.com/news/url?fd=R&amp;sa=T&amp;url=http%3A%2F%2Fdurangoherald.com%2Fsections%2FFeatures%2FColumnists%2FGreen_Medicine%2F2010%2F02%2F15%2FPrescription_medications_can_cause_nutritional_deficiencies%2F&amp;usg=AFQjCNHjV7yniIT1_j5R6bwUJYSS9HtxsA">Prescription medications can cause nutritional deficiencies</a><br />The Durango Herald<br />Anti-inflammatories: Steroids (Prednisone, Medrol, Decadron) cause deficiencies in calcium, vitamin D, magnesium, zinc, vitamin C, vitamins B6 and B12, <br /><br /><a rel="nofollow" target="_blank" class="p" href="http://news.google.com/news/more?pz=1&amp;ned=us&amp;ncl=dlOAzxcuOBa1phM"></a></p><p><br /><img alt="" height="1" width="1" /><a rel="nofollow" target="_blank" href="http://news.google.com/news/url?fd=R&amp;sa=T&amp;url=http%3A%2F%2Fwww.myelomabeacon.com%2Fnews%2F2010%2F02%2F11%2Frevlimid-cyclophosphamide-prednisone-combination-may-be-highly-effective-for-refractory-multiple-myeloma-patients%2F&amp;usg=AFQjCNG6pczTBxS2KwYQRlp7alTgQ5fvEQ">Revlimid-Cyclophosphamide-Prednisone Combination May Be Highly Effective For </a><br />The Myeloma Beacon<br />In addition to the RCP regimen, all patients received 100 mg aspirin daily for prevention of blood clots and 480 mg cotrimoxazol daily to prevent infection. <br /><br /><a rel="nofollow" target="_blank" class="p" href="http://news.google.com/news/more?pz=1&amp;ned=us&amp;ncl=djf-pCwRCZThFDM"></a></p><p><br /><img alt="" height="1" width="1" /><a rel="nofollow" target="_blank" href="http://news.google.com/news/url?fd=R&amp;sa=T&amp;url=http%3A%2F%2Fwww.myelomabeacon.com%2Fnews%2F2010%2F02%2F16%2Fmultiple-myeloma-total-therapy-regimen-claims-50-percent-cure-rate%2F&amp;usg=AFQjCNGH4l9FGlMRextaGto2otDuV84kxw">Multiple Myeloma Total Therapy Regimen Claims 50 Percent Cure Rate</a><br />The Myeloma Beacon<br />Patients received two cycles of VTD-PACE, which consists of Velcade (bortezomib), thalidomide (Thalomid), dexamethasone (Decadron), and four-day continuous <br /><br /><a rel="nofollow" target="_blank" class="p" href="http://news.google.com/news/more?pz=1&amp;ned=us&amp;ncl=dqEjE9z-Tp4X0KM"></a></p><p><br /><img alt="" height="1" width="1" /><a rel="nofollow" target="_blank" href="http://news.google.com/news/url?fd=R&amp;sa=T&amp;url=http%3A%2F%2Fwww.myelomabeacon.com%2Fnews%2F2010%2F02%2F17%2Fcurcumin-and-multiple-myeloma-preclinical-and-early-clinical-studies-are-promising-still-awaiting-more-clinical-evidence%2F&amp;usg=AFQjCNGUjazUGeMRqYhnwhFaAKDh7wY8sQ">Curcumin And Multiple Myeloma: Preclinical And Early Clinical Studies Are </a><br />The Myeloma Beacon<br />All of the studies discussed here suggest that curcumin is relatively safe. In India, where turmeric is used extensively in cooking, the average person <br /><br /><a rel="nofollow" target="_blank" class="p" href="http://news.google.com/news/more?pz=1&amp;ned=us&amp;ncl=dAWjKpeJL-snTzM"></a></p><p><br /><img alt="" height="1" width="1" /><a rel="nofollow" target="_blank" href="http://news.google.com/news/url?fd=R&amp;sa=T&amp;url=http%3A%2F%2Fwww.myelomabeacon.com%2Fnews%2F2010%2F02%2F12%2Frevlimid-maintenance-therapy-is-added-to-multiple-myeloma-treatment-guidelines%2F&amp;usg=AFQjCNFUTd5uTp2LfVWHKQo0WFiuNkz2OA">Revlimid Maintenance Therapy Is Added To Multiple Myeloma Treatment Guidelines</a><br />The Myeloma Beacon<br />Currently, Revlimid is only approved by the United States Food and Drug Administration (FDA) in combination with dexamethasone (Decadron) as a second-line <br /><br /><a rel="nofollow" target="_blank" class="p" href="http://news.google.com/news/more?pz=1&amp;ned=us&amp;ncl=dC_4MBG4Bdc8ctM"></a></p>]]></description>
<category>Decadron</category>
</item>
<item>
<title>Decadron News - Decadron side effects</title>
<link>http://genericdecadron.infohttp://genericdecadron.info/Decadron/Decadron-side-effects/</link>
<description><![CDATA[<p><br /><img alt="" height="1" width="1" /><a rel="nofollow" target="_blank" href="http://news.google.com/news/url?fd=R&amp;sa=T&amp;url=http%3A%2F%2Fwww.myelomabeacon.com%2Fnews%2F2010%2F02%2F23%2Fthe-top-myeloma-research-of-2009%2F&amp;usg=AFQjCNGLymoaCYEUd5hoyTa6pufZuOBYvQ">The Top Myeloma Research Of 2009</a><br />The Myeloma Beacon<br />Patients treated with VMPT had a greater response rate than those treated with VMP, but they also encountered more blood-related side effects. <br /><br /><a rel="nofollow" target="_blank" class="p" href="http://news.google.com/news/more?pz=1&amp;ned=us&amp;ncl=dNVNUhAHlusvaeM"></a></p><p><br /><img alt="" height="1" width="1" /><a rel="nofollow" target="_blank" href="http://news.google.com/news/url?fd=R&amp;sa=T&amp;url=http%3A%2F%2Fdurangoherald.com%2Fsections%2FFeatures%2FColumnists%2FGreen_Medicine%2F2010%2F02%2F15%2FPrescription_medications_can_cause_nutritional_deficiencies%2F&amp;usg=AFQjCNHjV7yniIT1_j5R6bwUJYSS9HtxsA">Prescription medications can cause nutritional deficiencies</a><br />The Durango Herald<br />Overprescribing supplements also can have harmful side effects. However, most Americans could safely take a good multivitamin and mineral supplement and be <br /><br /><a rel="nofollow" target="_blank" class="p" href="http://news.google.com/news/more?pz=1&amp;ned=us&amp;ncl=dlOAzxcuOBa1phM"></a></p><p><br /><img alt="" height="1" width="1" /><a rel="nofollow" target="_blank" href="http://news.google.com/news/url?fd=R&amp;sa=T&amp;url=http%3A%2F%2Fwww.myelomabeacon.com%2Fnews%2F2010%2F02%2F11%2Frevlimid-cyclophosphamide-prednisone-combination-may-be-highly-effective-for-refractory-multiple-myeloma-patients%2F&amp;usg=AFQjCNG6pczTBxS2KwYQRlp7alTgQ5fvEQ">Revlimid-Cyclophosphamide-Prednisone Combination May Be Highly Effective For </a><br />The Myeloma Beacon<br />The most common severe side effects observed included low white blood cell count (neutropenia), low red blood cell count (anemia), low platelet count <br /><br /><a rel="nofollow" target="_blank" class="p" href="http://news.google.com/news/more?pz=1&amp;ned=us&amp;ncl=djf-pCwRCZThFDM"></a></p><p><a rel="nofollow" target="_blank" href="http://news.google.com/news/url?fd=R&amp;sa=T&amp;url=http%3A%2F%2Fwww.osnsupersite.com%2Fview.aspx%3Frid%3D61205&amp;usg=AFQjCNEIcznSFHm2Mn5FLS4Ypy8G_5Z0Eg"><img src="http://nt0.ggpht.com/news/tbn/mGCe5_tzYcecsM/6.jpg" alt="" border="1" width="80" height="80" /><br />OSN SuperSite</a><br /><img alt="" height="1" width="1" /><a rel="nofollow" target="_blank" href="http://news.google.com/news/url?fd=R&amp;sa=T&amp;url=http%3A%2F%2Fwww.osnsupersite.com%2Fview.aspx%3Frid%3D61205&amp;usg=AFQjCNEIcznSFHm2Mn5FLS4Ypy8G_5Z0Eg">Surgical technique determines success of ECP</a><br />OSN SuperSite<br />Surgeons I have talked to suggest the two biggest deterrents to adopting ECP seem to be the side effect of inflammation and insufficient IOP reduction. <br /><br /><a rel="nofollow" target="_blank" class="p" href="http://news.google.com/news/more?pz=1&amp;ned=us&amp;ncl=dXss72pvl1NYqoM"></a></p><p><br /><img alt="" height="1" width="1" /><a rel="nofollow" target="_blank" href="http://news.google.com/news/url?fd=R&amp;sa=T&amp;url=http%3A%2F%2Fwww.myelomabeacon.com%2Fnews%2F2010%2F02%2F17%2Fcurcumin-and-multiple-myeloma-preclinical-and-early-clinical-studies-are-promising-still-awaiting-more-clinical-evidence%2F&amp;usg=AFQjCNGUjazUGeMRqYhnwhFaAKDh7wY8sQ">Curcumin And Multiple Myeloma: Preclinical And Early Clinical Studies Are </a><br />The Myeloma Beacon<br />Researchers reported that their study participants did not feel any significant side effects. They presented their findings at the American Society of <br /><br /><a rel="nofollow" target="_blank" class="p" href="http://news.google.com/news/more?pz=1&amp;ned=us&amp;ncl=dAWjKpeJL-snTzM"></a></p>]]></description>
<category>Decadron</category>
</item>
<item>
<title>decadron News - Decadron in chemotherapy</title>
<link>http://genericdecadron.infohttp://genericdecadron.info/decadron/Decadron-in-chemotherapy/</link>
<description><![CDATA[<p><br /><img alt="" height="1" width="1" /><a rel="nofollow" target="_blank" href="http://news.google.com/news/url?fd=R&amp;sa=T&amp;url=http%3A%2F%2Fwww.myelomabeacon.com%2Fnews%2F2010%2F03%2F03%2Fgenetic-risk-factors-and-treatment-history-may-predict-response-in-patients-with-relapsedrefractory-myeloma-study-finds%2F&amp;usg=AFQjCNFMxQny_E2OSgN2DVuCGSInv2kypg">Genetic Risk Factors And Treatment History May Predict Response In Patients </a><br />The Myeloma Beacon<br />A new study published in the journal Leukemia determined that when treated with Revlimid (lenalidomide) and dexamethasone (Decadron), relapsed and <br /><br /><a rel="nofollow" target="_blank" class="p" href="http://news.google.com/news/more?pz=1&amp;ned=us&amp;ncl=dD1WQok1H27YJhM"></a></p><p><br /><img alt="" height="1" width="1" /><a rel="nofollow" target="_blank" href="http://news.google.com/news/url?fd=R&amp;sa=T&amp;url=http%3A%2F%2Fwww.myelomabeacon.com%2Fnews%2F2010%2F03%2F01%2Finternational-effort-updates-results-from-multiple-myeloma-stem-cell-transplant-trials%2F&amp;usg=AFQjCNFaNZVObuJFyvDMS74rMIp0nWkcVg">International Effort Updates Results From Multiple Myeloma Stem Cell </a><br />The Myeloma Beacon<br />Induction with vincristine, doxorubicin (Adriamcyin), and dexamethasone (Decadron) followed by the M2 regimen: BiCNU (carmustine), melphalan, <br /><br /><a rel="nofollow" target="_blank" class="p" href="http://news.google.com/news/more?pz=1&amp;ned=us&amp;ncl=ddHaCHYPxm0HuWM"></a></p><p><br /><img alt="" height="1" width="1" /><a rel="nofollow" target="_blank" href="http://news.google.com/news/url?fd=R&amp;sa=T&amp;url=http%3A%2F%2Fwww.myelomabeacon.com%2Fnews%2F2010%2F02%2F19%2Fachieving-very-good-partial-response-indicates-a-good-prognosis-for-multiple-myeloma-patients-study-finds%2F&amp;usg=AFQjCNFJQqytcpd7zCATOgTLDrHA8Z0C0A">Achieving Very Good Partial Response Indicates A Good Prognosis For Multiple </a><br />The Myeloma Beacon<br />In both trials, patients received a combination induction therapy of vincristine (Oncovin), doxorubicin (Adriamycin), and dexamethasone (Decadron), <br /><br /><a rel="nofollow" target="_blank" class="p" href="http://news.google.com/news/more?pz=1&amp;ned=us&amp;ncl=dOIH7s4Nh8ryybM"></a></p><p><br /><img alt="" height="1" width="1" /><a rel="nofollow" target="_blank" href="http://news.google.com/news/url?fd=R&amp;sa=T&amp;url=http%3A%2F%2Fwww.myelomabeacon.com%2Fnews%2F2010%2F02%2F17%2Fcurcumin-and-multiple-myeloma-preclinical-and-early-clinical-studies-are-promising-still-awaiting-more-clinical-evidence%2F&amp;usg=AFQjCNGUjazUGeMRqYhnwhFaAKDh7wY8sQ">Curcumin And Multiple Myeloma: Preclinical And Early Clinical Studies Are </a><br />The Myeloma Beacon<br />She decided to try curcumin when her myeloma markers were worsening and her hematologist suggested she start chemotherapy. She told her doctor she wanted to <br /><br /><a rel="nofollow" target="_blank" class="p" href="http://news.google.com/news/more?pz=1&amp;ned=us&amp;ncl=dAWjKpeJL-snTzM"></a></p>]]></description>
<category>decadron</category>
</item>
<item>
<title>decadron News - Dexamethasone decadron</title>
<link>http://genericdecadron.infohttp://genericdecadron.info/decadron/Dexamethasone-decadron/</link>
<description><![CDATA[<p><br /><img alt="" height="1" width="1" /><a rel="nofollow" target="_blank" href="http://news.google.com/news/url?fd=R&amp;sa=T&amp;url=http%3A%2F%2Fwww.myelomabeacon.com%2Fnews%2F2010%2F03%2F03%2Fgenetic-risk-factors-and-treatment-history-may-predict-response-in-patients-with-relapsedrefractory-myeloma-study-finds%2F&amp;usg=AFQjCNFMxQny_E2OSgN2DVuCGSInv2kypg">Genetic Risk Factors And Treatment History May Predict Response In Patients </a><br />The Myeloma Beacon<br />A new study published in the journal Leukemia determined that when treated with Revlimid (lenalidomide) and dexamethasone (Decadron), relapsed and <br /><br /><a rel="nofollow" target="_blank" class="p" href="http://news.google.com/news/more?pz=1&amp;ned=us&amp;ncl=dD1WQok1H27YJhM"></a></p><p><br /><img alt="" height="1" width="1" /><a rel="nofollow" target="_blank" href="http://news.google.com/news/url?fd=R&amp;sa=T&amp;url=http%3A%2F%2Fwww.myelomabeacon.com%2Fnews%2F2010%2F02%2F25%2Fthalidomide-as-induction-and-maintenance-therapy-improves-response-rates-in-multiple-myeloma-patients%2F&amp;usg=AFQjCNFSX1MB6SN7Abk9O4PPAppb7Mm2JA">Thalidomide As Induction And Maintenance Therapy Improves Response Rates In </a><br />The Myeloma Beacon<br /> doxorubicin, and dexamethasone [VAD] or thalidomide, doxorubicin (Adriamycin), and dexamethasone (Decadron) [TAD] as induction therapy. <br /><br /><a rel="nofollow" target="_blank" class="p" href="http://news.google.com/news/more?pz=1&amp;ned=us&amp;ncl=dNyKsXPFbabQDEM"></a></p><p><br /><img alt="" height="1" width="1" /><a rel="nofollow" target="_blank" href="http://news.google.com/news/url?fd=R&amp;sa=T&amp;url=http%3A%2F%2Fwww.myelomabeacon.com%2Fnews%2F2010%2F02%2F23%2Fthe-top-myeloma-research-of-2009%2F&amp;usg=AFQjCNGLymoaCYEUd5hoyTa6pufZuOBYvQ">The Top Myeloma Research Of 2009</a><br />The Myeloma Beacon<br /> in 2009 evaluated a combination of pomalidomide (Actimid, CC-4047) and low-dose dexamethasone (Decadron) in relapsed and refractory myeloma patients. <br /><br /><a rel="nofollow" target="_blank" class="p" href="http://news.google.com/news/more?pz=1&amp;ned=us&amp;ncl=dNVNUhAHlusvaeM"></a></p><p><br /><img alt="" height="1" width="1" /><a rel="nofollow" target="_blank" href="http://news.google.com/news/url?fd=R&amp;sa=T&amp;url=http%3A%2F%2Fwww.myelomabeacon.com%2Fnews%2F2010%2F02%2F11%2Frevlimid-cyclophosphamide-prednisone-combination-may-be-highly-effective-for-refractory-multiple-myeloma-patients%2F&amp;usg=AFQjCNG6pczTBxS2KwYQRlp7alTgQ5fvEQ">Revlimid-Cyclophosphamide-Prednisone Combination May Be Highly Effective For </a><br />The Myeloma Beacon<br /> prednisone (RCP) is highly effective in multiple myeloma patients who are refractory (not responsive) to Revlimid-dexamethasone (Decadron) treatment. <br /><br /><a rel="nofollow" target="_blank" class="p" href="http://news.google.com/news/more?pz=1&amp;ned=us&amp;ncl=djf-pCwRCZThFDM"></a></p><p><a rel="nofollow" target="_blank" href="http://news.google.com/news/url?fd=R&amp;sa=T&amp;url=http%3A%2F%2Fwww.osnsupersite.com%2Fview.aspx%3Frid%3D61205&amp;usg=AFQjCNEIcznSFHm2Mn5FLS4Ypy8G_5Z0Eg"><img src="http://nt0.ggpht.com/news/tbn/mGCe5_tzYcecsM/6.jpg" alt="" border="1" width="80" height="80" /><br />OSN SuperSite</a><br /><img alt="" height="1" width="1" /><a rel="nofollow" target="_blank" href="http://news.google.com/news/url?fd=R&amp;sa=T&amp;url=http%3A%2F%2Fwww.osnsupersite.com%2Fview.aspx%3Frid%3D61205&amp;usg=AFQjCNEIcznSFHm2Mn5FLS4Ypy8G_5Z0Eg">Surgical technique determines success of ECP</a><br />OSN SuperSite<br />His team injects Decadron (dexamethasone, Merck) into a patient&#39;s eye immediately after surgery and then continues to treat them with it intravenously <br /><br /><a rel="nofollow" target="_blank" class="p" href="http://news.google.com/news/more?pz=1&amp;ned=us&amp;ncl=dXss72pvl1NYqoM"></a></p><p><br /><img alt="" height="1" width="1" /><a rel="nofollow" target="_blank" href="http://news.google.com/news/url?fd=R&amp;sa=T&amp;url=http%3A%2F%2Fwww.kelowna.com%2F2010%2F02%2F17%2Fchuck-poulsen-pharmaceutical-companies-a-pain-in-the-butt&amp;usg=AFQjCNFaxw_wGesYhYYtkjsGWqyMg2bEsg">Chuck Poulsen: Pharmaceutical companies a pain in the butt</a><br />Kelowna.com<br />The gold standard is an injection of Decadron (dexamethasone). That&#39;s a powerful corticosteroid. An attack of edema was coming on so I went to the local <br /><br /><a rel="nofollow" target="_blank" class="p" href="http://news.google.com/news/more?pz=1&amp;ned=us&amp;ncl=dV4cBEAbF7x-_zM">and more&nbsp;&raquo;</a></p><p><br /><img alt="" height="1" width="1" /><a rel="nofollow" target="_blank" href="http://news.google.com/news/url?fd=R&amp;sa=T&amp;url=http%3A%2F%2Fwww.myelomabeacon.com%2Fnews%2F2010%2F03%2F01%2Finternational-effort-updates-results-from-multiple-myeloma-stem-cell-transplant-trials%2F&amp;usg=AFQjCNFaNZVObuJFyvDMS74rMIp0nWkcVg">International Effort Updates Results From Multiple Myeloma Stem Cell </a><br />The Myeloma Beacon<br />Induction with vincristine, doxorubicin (Adriamcyin), and dexamethasone (Decadron) followed by the M2 regimen: BiCNU (carmustine), melphalan, <br /><br /><a rel="nofollow" target="_blank" class="p" href="http://news.google.com/news/more?pz=1&amp;ned=us&amp;ncl=ddHaCHYPxm0HuWM"></a></p><p><br /><img alt="" height="1" width="1" /><a rel="nofollow" target="_blank" href="http://news.google.com/news/url?fd=R&amp;sa=T&amp;url=http%3A%2F%2Fwww.medpagetoday.com%2FMeetingCoverage%2FAAAAIMeeting%2F18720&amp;usg=AFQjCNGHZ9qhiX14uRoJsaEKP3RRXAgV-Q">AAAAI: Vitamin D Levels Linked to Asthma Meds</a><br />MedPage Today<br /> D improved anti-inflammatory markers MKP-1 and interleukin (IL)-10 and enhanced the activity of dexamethasone (Decadron, Dexpak) more than 10-fold. <br /><br /><a rel="nofollow" target="_blank" class="p" href="http://news.google.com/news/more?pz=1&amp;ned=us&amp;ncl=dALoNdjrCtYSCCM"></a></p><p><br /><img alt="" height="1" width="1" /><a rel="nofollow" target="_blank" href="http://news.google.com/news/url?fd=R&amp;sa=T&amp;url=http%3A%2F%2Fwww.myelomabeacon.com%2Fnews%2F2010%2F02%2F16%2Fmultiple-myeloma-total-therapy-regimen-claims-50-percent-cure-rate%2F&amp;usg=AFQjCNGH4l9FGlMRextaGto2otDuV84kxw">Multiple Myeloma Total Therapy Regimen Claims 50 Percent Cure Rate</a><br />The Myeloma Beacon<br />Patients received two cycles of VTD-PACE, which consists of Velcade (bortezomib), thalidomide (Thalomid), dexamethasone (Decadron), and four-day continuous <br /><br /><a rel="nofollow" target="_blank" class="p" href="http://news.google.com/news/more?pz=1&amp;ned=us&amp;ncl=dqEjE9z-Tp4X0KM"></a></p><p><br /><img alt="" height="1" width="1" /><a rel="nofollow" target="_blank" href="http://news.google.com/news/url?fd=R&amp;sa=T&amp;url=http%3A%2F%2Fwww.myelomabeacon.com%2Fnews%2F2010%2F02%2F19%2Fachieving-very-good-partial-response-indicates-a-good-prognosis-for-multiple-myeloma-patients-study-finds%2F&amp;usg=AFQjCNFJQqytcpd7zCATOgTLDrHA8Z0C0A">Achieving Very Good Partial Response Indicates A Good Prognosis For Multiple </a><br />The Myeloma Beacon<br />In both trials, patients received a combination induction therapy of vincristine (Oncovin), doxorubicin (Adriamycin), and dexamethasone (Decadron), <br /><br /><a rel="nofollow" target="_blank" class="p" href="http://news.google.com/news/more?pz=1&amp;ned=us&amp;ncl=dOIH7s4Nh8ryybM"></a></p>]]></description>
<category>decadron</category>
</item>
<item>
<title>decadron online News - Decadron and cpt code</title>
<link>http://genericdecadron.infohttp://genericdecadron.info/decadron-online/Decadron-and-cpt-code/</link>
<description><![CDATA[<p><br /><img alt="" height="1" width="1" /><a rel="nofollow" target="_blank" href="http://news.google.com/news/url?fd=R&amp;sa=T&amp;url=http%3A%2F%2Fwww.myelomabeacon.com%2Fnews%2F2010%2F02%2F23%2Fthe-top-myeloma-research-of-2009%2F&amp;usg=AFQjCNGLymoaCYEUd5hoyTa6pufZuOBYvQ">The Top Myeloma Research Of 2009</a><br />The Myeloma Beacon<br /> in 2009 evaluated a combination of pomalidomide (Actimid, CC-4047) and low-dose dexamethasone (Decadron) in relapsed and refractory myeloma patients. <br /><br /><a rel="nofollow" target="_blank" class="p" href="http://news.google.com/news/more?pz=1&amp;ned=us&amp;ncl=dNVNUhAHlusvaeM"></a></p><p><br /><img alt="" height="1" width="1" /><a rel="nofollow" target="_blank" href="http://news.google.com/news/url?fd=R&amp;sa=T&amp;url=http%3A%2F%2Fwww.myelomabeacon.com%2Fnews%2F2010%2F02%2F17%2Fcurcumin-and-multiple-myeloma-preclinical-and-early-clinical-studies-are-promising-still-awaiting-more-clinical-evidence%2F&amp;usg=AFQjCNGUjazUGeMRqYhnwhFaAKDh7wY8sQ">Curcumin And Multiple Myeloma: Preclinical And Early Clinical Studies Are </a><br />The Myeloma Beacon<br /> that curcumin slowed down the growth of multiple myeloma cells that are resistant to dexamethasone (Decadron), doxorubicin (Adriamycin), and melphalan. <br /><br /><a rel="nofollow" target="_blank" class="p" href="http://news.google.com/news/more?pz=1&amp;ned=us&amp;ncl=dAWjKpeJL-snTzM"></a></p>]]></description>
<category>decadron online</category>
</item>
<item>
<title>Decadron News - Drug rash after taking decadron</title>
<link>http://genericdecadron.infohttp://genericdecadron.info/Decadron/Drug-rash-after-taking-decadron/</link>
<description><![CDATA[<p><br /><img alt="" height="1" width="1" /><a rel="nofollow" target="_blank" href="http://news.google.com/news/url?fd=R&amp;sa=T&amp;url=http%3A%2F%2Fwww.medicalnewstoday.com%2Farticles%2F179819.php&amp;usg=AFQjCNH9_DV9HsWTTpJ6Wi7qY06JNFGhFg">What Is Altitude Sickness (acute Mountain Sickness)? What Causes Altitude </a><br />Medical News Today<br />As blood pressure can suddenly drop after taking this medication, patients are advised not to get up too quickly. What are the possible complications of <br /><br /><a rel="nofollow" target="_blank" class="p" href="http://news.google.com/news/more?pz=1&amp;ned=us&amp;ncl=d9kX2a-f4cMmXnM"></a></p><p><br /><img alt="" height="1" width="1" /><a rel="nofollow" target="_blank" href="http://news.google.com/news/url?fd=R&amp;sa=T&amp;url=http%3A%2F%2Fwww.marketwatch.com%2Fstory%2Fnovartis-drug-tasignar-receives-fda-priority-review-for-newly-diagnosed-patients-with-early-stage-chronic-myeloid-leukemia-2010-02-19%3Freflink%3DMW_news_stmp&amp;usg=AFQjCNEhKtpc1XFvj5FRNxHdxv2nnoX0Ww">Novartis Drug Tasigna(R) Receives FDA Priority Review for Newly Diagnosed </a><br />MarketWatch (press release)<br />Patients should avoid food 2 hours before and 1 hour after taking dose. A dose reduction is recommended in patients with hepatic impairment. <br /><br /><a rel="nofollow" target="_blank" class="p" href="http://news.google.com/news/more?pz=1&amp;ned=us&amp;ncl=de_Tv-z3pGm-zCM">and more&nbsp;&raquo;</a></p>]]></description>
<category>Decadron</category>
</item>
</channel>
</rss>